Arsenal Capital has merged Cello Health and four of its other firms to launch Lumanity, offering medical sector product development, market access and
commercialization services.
Vespa Capital has announced its investment into Digital Technology Advisory Group Ltd (DTAG), a group providing marketing strategy consulting, data-driven market research insights and tech-enabled communications solutions, an acquisition from Cello Health.
NEW YORK, Aug. 11, 2020 /PRNewswire/ – Arsenal Capital Partners (“Arsenal”), a specialized private equity firm investing in healthcare and industrials companies, has completed the acquisition of Cello Health plc (“Cello Health”), the global healthcare-focused advisory firm, for a total enterprise value of £181.8 million.
Cello Health plc (AIM: CLL), the healthcare-led advisory group, is pleased to announce the acquisition of the trade and assets of Innovative Science Solutions, LLP (“ISS”).
In announcing Cello’s Interim results 2013, Mark Scott, Chief Executive, commented: “The refocusing of the Group last year into Cello Health and Cello Consumer has begun to demonstrate its potential to deliver strong performance…..”
In announcing Cello’s Interim results 2013, Mark Scott, Chief Executive, commented: “The refocusing of the Group last year into Cello Health and Cello Consumer has begun to demonstrate its potential to deliver strong performance…..”
Cello Group plc, the insight and strategic marketing group, announces the acquisition of Mash Health Limited and Mash Health, Inc. Initial consideration is approximately £0.6 million, with further performance related consideration of up to a maximum of £0.9 million.
